CYP2C19 phenoconversion by routinely prescribed proton pump inhibitors omeprazole and esomeprazole: Clinical implications for personalized medicine - Klieber, M; Oberacher, H; Hofstaetter, S (J Pharmacol Exp Ther, 2015)